These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35545387)

  • 1. Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) - a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway.
    Forster RB; Strandberg RB; Bø Tibballs KL; Nøkleby K; Berg TJ; Iversen T; Hagen TP; Richardsen KR; Cooper J; Sandberg S; Løvaas KF; Nilsen RM; Iversen MM; Jenum AK; Buhl ESS
    BMJ Open; 2022 May; 12(5):e054840. PubMed ID: 35545387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway.
    Igland J; Forster R; Jenum AK; Strandberg RB; Berg TJ; Røssberg JI; Iversen MM; Buhl ES
    BMJ Open; 2024 Mar; 14(3):e077027. PubMed ID: 38548358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults.
    Carlsen S; Skrivarhaug T; Thue G; Cooper JG; Gøransson L; Løvaas K; Sandberg S
    Pediatr Diabetes; 2017 May; 18(3):188-195. PubMed ID: 26875589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing with Learning Disability and Diabetes: OK-Diabetes - a case-finding study and feasibility randomised controlled trial.
    House A; Bryant L; Russell AM; Wright-Hughes A; Graham L; Walwyn R; Wright JM; Hulme C; O'Dwyer JL; Latchford G; Meer S; Birtwistle JC; Stansfield A; Ajjan R; Farrin A
    Health Technol Assess; 2018 May; 22(26):1-328. PubMed ID: 29845932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cross-sectional view of the current state of treatment of youth with type 2 diabetes in the USA: enrollment data from the Pediatric Diabetes Consortium Type 2 Diabetes Registry.
    Nambam B; Silverstein J; Cheng P; Ruedy KJ; Beck RW; Paul Wadwa R; Klingensmith G; Willi SM; Wood JR; Bacha F; Thomas IH; Tamborlane WV;
    Pediatr Diabetes; 2017 May; 18(3):222-229. PubMed ID: 26970319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duration of type 2 diabetes and remission rates after bariatric surgery in Sweden 2007-2015: A registry-based cohort study.
    Jans A; Näslund I; Ottosson J; Szabo E; Näslund E; Stenberg E
    PLoS Med; 2019 Nov; 16(11):e1002985. PubMed ID: 31747392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK.
    McGovern A; Hinton W; Correa A; Munro N; Whyte M; de Lusignan S
    BMJ Open; 2016 Nov; 6(11):e012801. PubMed ID: 27884846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in glycaemic control, monitoring, and treatment of type 2 diabetes in England: A retrospective cohort analysis.
    Whyte MB; Hinton W; McGovern A; van Vlymen J; Ferreira F; Calderara S; Mount J; Munro N; de Lusignan S
    PLoS Med; 2019 Oct; 16(10):e1002942. PubMed ID: 31589609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Hoorn Diabetes Care System (DCS) cohort. A prospective cohort of persons with type 2 diabetes treated in primary care in the Netherlands.
    van der Heijden AA; Rauh SP; Dekker JM; Beulens JW; Elders P; 't Hart LM; Rutters F; van Leeuwen N; Nijpels G
    BMJ Open; 2017 Jun; 7(5):e015599. PubMed ID: 28588112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of type 1 diabetes in the specialist health service--data from the Norwegian Diabetes Register for Adults.
    Cooper JG; Claudi T; Thordarson HB; Løvaas KF; Carlsen S; Sandberg S; Thue G
    Tidsskr Nor Laegeforen; 2013 Nov; 133(21):2257-62. PubMed ID: 24226332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multimorbidity, mortality, and HbA1c in type 2 diabetes: A cohort study with UK and Taiwanese cohorts.
    Chiang JI; Hanlon P; Li TC; Jani BD; Manski-Nankervis JA; Furler J; Lin CC; Yang SY; Nicholl BI; Thuraisingam S; Mair FS
    PLoS Med; 2020 May; 17(5):e1003094. PubMed ID: 32379755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialist-led diabetes registries and predictors of poor glycemic control in type 2 diabetes: Insights into the functionally refractory patient from the LMC Diabetes Registry database.
    Aronson R; Orzech N; Ye C; Goldenberg R; Brown V
    J Diabetes; 2016 Jan; 8(1):76-85. PubMed ID: 25565383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The total prevalence of diagnosed diabetes and the quality of diabetes care for the adult population in Salten, Norway.
    Slåtsve KB; Claudi T; Lappegård KT; Jenum AK; Larsen M; Cooper JG; Sandberg S; Julsrud Berg T
    Scand J Public Health; 2022 Mar; 50(2):161-171. PubMed ID: 32854596
    [No Abstract]   [Full Text] [Related]  

  • 14. Inequalities in glycemic control in childhood onset type 2 diabetes in England and Wales-A national population-based longitudinal study.
    Khanolkar AR; Amin R; Taylor-Robinson D; Viner RM; Warner J; Stephenson T
    Pediatr Diabetes; 2019 Nov; 20(7):821-831. PubMed ID: 31329349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic Minorities Are at Greater Risk for Childhood-Onset Type 2 Diabetes and Poorer Glycemic Control in England and Wales.
    Khanolkar AR; Amin R; Taylor-Robinson D; Viner R; Warner J; Stephenson T
    J Adolesc Health; 2016 Sep; 59(3):354-361. PubMed ID: 27426206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population.
    Kauppila T; Laine MK; Honkasalo M; Raina M; Eriksson JG
    Scand J Prim Health Care; 2016 Sep; 34(3):267-73. PubMed ID: 27404014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with glycaemic control in adults with Type 1 diabetes: a registry-based analysis including 7601 individuals from 34 centres in Norway.
    Cooper JG; Bakke Å; Dalen I; Carlsen S; Skeie S; Løvaas KF; Sandberg S; Thue G
    Diabet Med; 2020 May; 37(5):828-837. PubMed ID: 31469928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations between multimorbidity and glycaemia (HbA1c) in people with type 2 diabetes: cross-sectional study in Australian general practice.
    Chiang JI; Furler J; Mair F; Jani BD; Nicholl BI; Thuraisingam S; Manski-Nankervis JA
    BMJ Open; 2020 Nov; 10(11):e039625. PubMed ID: 33243798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014.
    Tran AT; Bakke Å; Berg TJ; Gjelsvik B; Mdala I; Nøkleby K; Shakil Rai A; Cooper JG; Claudi T; Løvaas K; Thue G; Sandberg S; Jenum AK
    Scand J Prim Health Care; 2018 Jun; 36(2):170-179. PubMed ID: 29717939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study.
    Zabala A; Darsalia V; Holzmann MJ; Franzén S; Svensson AM; Eliasson B; Patrone C; Nyström T; Jonsson M
    Diabetes Obes Metab; 2020 Feb; 22(2):182-190. PubMed ID: 31576643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.